Komori
Other Disclosures4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Eiken Chemical launches a new radio commercial on the theme of colorectal cancer screening — Early detection can make a major difference to what follows

Eiken Chemical produced a new radio commercial highlighting the importance of colorectal cancer screening and began airing it on Nippon Broadcasting System on 9 April 2026.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Radio commercial, “The 90% Batter” version
Applicable field (uses covered by this announcement)

Colorectal cancer screening awareness, health and healthcare

Launch date9 April 2026 (actual)
Relationship between the counterparty and the company
EIKEN CHEMICAL CO.,LTD.4549
Relationship with the Company

Eiken Chemical uses Nippon Broadcasting System as the advertising medium and broadcaster for airing its commercial.

CounterpartyNippon Broadcasting System

Radio broadcaster. Other details: Not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredRadio commercial, “The 90% Batter” version
CounterpartyNippon Broadcasting System
Counterparty overviewRadio broadcaster. Other details: Not disclosed.
Relationship with the CompanyEiken Chemical uses Nippon Broadcasting System as the advertising medium and broadcaster for airing its commercial.
Launch date9 April 2026 (actual)
Applicable areaColorectal cancer screening awareness, health and healthcare
Items this document does not state (12)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To deepen understanding of colorectal cancer screening, communicate early detection as an option, and encourage people to think about their own health.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Eiken Chemical launches a new radio commercial on the theme of colorectal cancer screening — Early detection can make a major difference to what follows | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori